XML 68 R44.htm IDEA: XBRL DOCUMENT v3.26.1
Parent Only Information (Tables)
12 Months Ended
Dec. 31, 2025
Parent Only Information [Abstract]  
Schedule of Condensed Balance Sheets Condensed Balance Sheets
   As of
December 31,
2024
   As of
December 31,
2025
 
   US$   US$ 
Assets        
Cash   313    85 
Amounts due from related parties   23,790    21,799 
Long-term investment   50    50 
Crypto Assets   403    792 
Total Assets   24,556    22,726 
Liabilities          
Accounts payable   72     
Accrued payroll   22    29 
Operating lease liabilities-current   1    1 
Investments in subsidiaries   10,095    15,297 
Total Liabilities   10,190    15,327 
Equity:          
Class A Common Shares, $0.0015 par value; 22,024,624 shares authorized, 1,190,317 and 1,110,907 shares issued and outstanding in December 31, 2025 and December 31, 2024.   1    2 
Class B Ordinary shares ($0.0015 par value; 642,043 shares authorized and outstanding on December 31, 2025 and December 31, 2024)   1    1 
Additional paid-in capital   52,137    52,192 
accumulated deficit   (37,231)   (44,283)
Accumulated other comprehensive loss   (542)   (513)
Total equity   14,366    7,399 
Total Liabilities and Equity   24,556    22,726 
Schedule of Condensed Statements of Operations Condensed Statements of Operations
   For the years ended December 31, 
   2023   2024   2025 
   US$   US$   US$ 
Revenue   1,497    1,015    382 
Cost of revenue   (1,134)   (919)   (431)
General and administrative expenses   (1,583)   (1,025)   (1,329)
Sales and marketing expenses   (63)   (34)   (41)
Other expense, net   31    13    178 
Share of loss from subsidiaries   (4,868)   (4,936)   (5,213)
Net loss   (6,120)   (5,886)   (6,454)
Schedule of Condensed Statements of Cash Flows Condensed Statements of Cash Flows
   For the years ended December 31, 
   2023   2024   2025 
   US$   US$   US$ 
Cash flows used in operating activities   (2,150)   461    (2,219)
Investment in subsidiaries            
Collection of due from/(increase in due from) subsidiaries   (6,782)   (601)   1,991 
Cash flows (used in) provide by  investing activities   (6,782)   (601)   1,991 
Reverse Recapitalization   9         
Cash flows from financing activities   9         
Effect of exchange rate changes            
Net change in cash and cash equivalents   (8,923)   (140)   (228)
Cash and cash equivalents at beginning of the period   9,376    453    313 
Cash and cash equivalents at end of the period   453    313    85